Address
304 North Cardinal
St. Dorchester Center, MA 02124
Work Hours
Monday to Sunday: 7AM - 12PM
Address
304 North Cardinal
St. Dorchester Center, MA 02124
Work Hours
Monday to Sunday: 7AM - 12PM

$300.00
Wegovy Semaglutide 1.7mg Pen assists long-term weight management in adults with obesity, or those who are overweight, with other health conditions.
Wegovy Semaglutide 1.7mg Pen assists long-term weight management in adults with obesity, or those who are overweight, with other health conditions. Healthcare providers use it in conjunction with a medically supervised weight-loss plan involving a balanced, reduced-calorie diet, and increased physical activity. Wegovy contains semaglutide, a medication that helps control hunger and consumption of food, thereby enabling users to manage their weight more effectively.
Semaglutide acts as the active ingredient in Wegovy and classifies as a GLP-1 receptor agonist. This class of medications mimics the action of a natural hormone called glucagon-like peptide-1 (GLP-1) that regulates appetite, blood sugar control, and digestion. Semaglutide acts on the appetite control center in the brain to reduce appetite and increase the sensation of fullness. It also prolongs gastric emptying, which helps to increase the time users feel full.
The 1.7mg Wegovy dose often classifies as a later step in the dose escalation schedule. Patients starting a new treatment typically initiate on a lower dose, like 0.25mg. Healthcare providers use gradual dose escalation as a tactic so the body can physiologically acclimate to the new medication. After several weeks of treatment, they introduce 1.7mg to assist in the improvement of appetite control and additional weight-loss benefits before reaching the final maintenance dose. In order to minimize the potential for gastrointestinal side effects, healthcare providers employ this escalation.
The Wegovy 1.7mg pre-filled pen was designed to be convenient and easy to use. Each pen contains a single dose meant to be injected weekly via a subcutaneous injection. Users can administer injections in the abdomen, thigh, or upper arm. Each pen is pre-filled, so users do not need to measure any doses or prepare any medication beforehand. This design allows patients to feel confident in consistency when administering the medication from home.
Research shows that with lifestyle changes, semaglutide helps patients lose weight. Wegovy decreases appetite and calorie consumption, thus aiding patients in losing weight over time. It also positively impacts patients’ blood sugars, cholesterol, and blood pressure.
Users of Wegovy may experience side effects. These include nausea, vomiting, diarrhea, constipation, and stomach pains. These side effects typically remain mild to moderate and tend to lessen over time. Patients should follow their healthcare provider’s instructions and should report severe side effects or those that do not go away.
Wegovy (Semaglutide) 1.7mg Pre-Filled Pen serves as one of the most critical components of the Wegovy treatment plan for weight management, given that it is one of the few capable of providing appetite suppression and sustaining weight loss over time. When patients use it under medical supervision and combine it with lifestyle changes, it can greatly improve their health
Reviews
There are no reviews yet.